Scientific Officer BioAgilytix Overland Park, Kansas
Join Amanda Hays and several authors in Poster Forum #4 in the Solution Center (Exhibit Halls 3 & 4) for a conversation about posters on the topic, “Advancements and Innovation in Drug Development”, that she is especially excited about.
T0930-01-02 Advancing Biomarker Assay Validation: From Supportive Secondary Endpoint to Primary Endpoint for Regulatory Decision Making in Generalized Myasthenia Gravis, Philip DeDecker, MS, Argenx
M1530-01-03 Singlicate Analysis of Anti-Antigen IgA in Human Serum with Ligand-Binding Assay, Wangxi Luo, Ph.D., Moderna
T0930-01-06 Improved SPR Signal Enhancement in Bioanalytical Assays Using Micropolymer-Conjugated IHC Reagents, Christopher Sucato, Ph.D., Novartis
M0930-05-27 In Vivo Preclinical Pharmacokinetics of Nortriptyline and Its Application to Develop a Physiologically Based Pharmacokinetic Model, Prachi Agrawal, MS, University of Nebraska Medical Center
T1330-01-05 CTLA4 SPLEX Assay Validation and Analysis on Disease and Healthy Donor Sample, Fizal N. Nabbie, Ph.D., Bristol-Myers Squibb Company